To Establish a Strategic Active Pharmaceutical Ingredient Reserve to Maintain a Domestic Supply of Active Pharmaceutical Ingredients and Key Starting Materials Needed for the Manufacturing of Essential Generic Medicines, and to Build a Pipeline for Domestic Active Pharmaceutical Ingredient Production.

H.R. 7709 (118th Congress)